Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
F HorakA Didier

Abstract

The optimal dose (300IR) of a five-grass pollen sublingual immunotherapy tablet in terms of efficacy was previously demonstrated from the first pollen season. Here, we aim to confirm whether this dose remained optimal during the peak of the pollen season by assessing the efficacy and quality of life data. A total of 628 subjects with grass pollen rhinoconjunctivitis were randomized in a double-blind, placebo-controlled, multi-centre, pan-European trial. Subjects received once-daily tablets (Stallergenes, Antony, France) of 100IR, 300IR, 500IR or placebo, starting 4 months before and throughout the 2005 grass pollen season. The pollen season was defined as the first day of 3 consecutive days with a grass pollen count above 30 grains/m(3) of air, recorded using Hirst-type volumetric pollen traps, to the last day before 3 consecutive days with a pollen count below 30 grains/m(3). The grass pollen season lasted an average of 30 days, with a peak of 12 days. The mean treatment duration before the grass pollen season was similar in the four treatment groups (121.4+/-31.1 to 128.6+/-15.4 days in the safety population). Both the 300IR and 500IR groups had highly significant improvements in Rhinoconjunctivitis Total Symptom Score (RTSS)...Continue Reading

References

Aug 8, 2006·The Journal of Allergy and Clinical Immunology·Ronald DahlStephen R Durham
May 25, 2007·Allergy·G D'AmatoP van Cauwenberge
Mar 26, 2008·International Archives of Allergy and Immunology·Philippe MoingeonGabriel Peltre

❮ Previous
Next ❯

Citations

Mar 7, 2012·American Journal of Rhinology & Allergy·Sarah K Wise, Rodney J Schlosser
Dec 22, 2012·Immunotherapy·Juliane Köberlein, Ralph Mösges
Feb 22, 2012·Immunotherapy·Philippe Moingeon, Laurent Mascarell
Sep 12, 2015·Expert Review of Clinical Immunology·Giorgio CiprandiAmelia Licari
Sep 4, 2015·Drug Discovery Today·Jørgen Nedergaard LarsenHenrik Jacobi
Aug 4, 2009·The Journal of Allergy and Clinical Immunology·Friedrich HorakMartine Le Gall
Aug 20, 2010·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Susanne HalkenUlrich Wahn
Nov 3, 2010·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H W ChuA J Wardlaw
Jan 22, 2014·Journal of Evaluation in Clinical Practice·George Dranitsaris, Anne K Ellis
Apr 30, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M A CalderonH Nolte
Aug 3, 2010·The Journal of Allergy and Clinical Immunology·Danilo Di BonaGabriele Di Lorenzo
Oct 2, 2012·The Journal of Allergy and Clinical Immunology·Danilo Di BonaGabriele Di Lorenzo
May 4, 2016·Immunotherapy·Philippe MoingeonLaurent Mascarell
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Ashley M CroftSushil Kumar
Jul 8, 2011·The Cochrane Database of Systematic Reviews·Moises A CalderonStephen Durham
Oct 22, 2014·American Journal of Rhinology & Allergy·Elie SerranoClaus Bachert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.